Stephen Feider - 27 Feb 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Signature
/s/ Stephen Feider
Issuer symbol
BBNX
Transactions as of
27 Feb 2025
Net transactions value
$0
Form type
4
Filing time
03 Mar 2025, 17:45:08 UTC
Previous filing
03 Feb 2025
Next filing
04 Jun 2025

Quoteable Key Fact

"Stephen Feider filed Form 4 for Beta Bionics, Inc. (BBNX) on 03 Mar 2025."

Quick Takeaways

  • This page summarizes Stephen Feider's Form 4 filing for Beta Bionics, Inc. (BBNX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 03 Mar 2025, 17:45.

What Changed

  • Previous filing in this sequence was filed on 03 Feb 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBNX Common Stock Award $0 +47,000 $0.000000 47,000 27 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBNX Employee Stock Option (right to buy) Award $0 +71,000 $0.000000 71,000 27 Feb 2025 Common Stock 71,000 $19.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
F2 The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .